These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 12218613

  • 1. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S, Satar B, Aydin N.
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [Abstract] [Full Text] [Related]

  • 2. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J, Kobierska-Gulida G, Izycka-Swieszewska E, Potocka M, Mikaszewski B, Sierszeń W.
    Otolaryngol Pol; 2010 Sep; 64(4):219-24. PubMed ID: 20873097
    [Abstract] [Full Text] [Related]

  • 3. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
    Kuczkowski J, Sakowicz-Burkiewicz M, Iżycka-Świeszewska E, Mikaszewski B, Pawełczyk T.
    ORL J Otorhinolaryngol Relat Spec; 2011 Sep; 73(2):93-9. PubMed ID: 21311206
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
    Akimoto R, Pawankar R, Yagi T, Baba S.
    ORL J Otorhinolaryngol Relat Spec; 2000 Sep; 62(5):257-65. PubMed ID: 10965261
    [Abstract] [Full Text] [Related]

  • 9. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
    Lee RJ, Sidey C, Narula AA, James RF.
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
    [Abstract] [Full Text] [Related]

  • 10. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha.
    Kurihara A, Toshima M, Yuasa R, Takasaka T.
    Ann Otol Rhinol Laryngol; 1991 Dec; 100(12):989-98. PubMed ID: 1746847
    [Abstract] [Full Text] [Related]

  • 11. Bone resorption in chronic otitis media: the role of the osteoclast.
    Jung JY, Chole RA.
    ORL J Otorhinolaryngol Relat Spec; 2002 Dec; 64(2):95-107. PubMed ID: 12021500
    [Abstract] [Full Text] [Related]

  • 12. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y, Kojima H, Miyazaki H, Koga T, Moriyama H.
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
    Li Z, Li X, Liu G.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M, Alpay HC, Orhan I, Onalan EE, Yanilmaz M, Sapmaz E.
    Am J Otolaryngol; 2013 Feb; 34(6):652-7. PubMed ID: 23927997
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.